PSTXPoseida Therapeutics Inc
Slide 1 of 3
Company Overview
Name
Poseida Therapeutics Inc
52W High
$9.67
52W Low
$1.87
Market Cap
$925.9M
Dividend Yield
0%
Price/earnings
0.21
P/E
0.21
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$71.7M
Operating Revenue
$71.7M
Total Gross Profit
$71.7M
Total Operating Income
$19.7M
Net Income
$20.2M
EV to EBITDA
-$1.24
EV to Revenue
$5.16
Price to Book value
Price to Earnings
-$2.61
Additional Data
Selling, General & Admin Expense
$10.1M
Research & Development Expense
$41.9M
Total Operating Expenses
$-52M
Interest Expense
$-2.3M
Other Income / (Expense), net
$2.8M
Total Other Income / (Expense), net
$536K
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Poseida Therapeutics Inc
52W High
$9.67
52W Low
$1.87
Market Cap
$925.9M
Dividend Yield
0%
Price/earnings
0.21
P/E
0.21
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$71.7M
Operating Revenue
$71.7M
Total Gross Profit
$71.7M
Total Operating Income
$19.7M
Net Income
$20.2M
EV to EBITDA
-$1.24
EV to Revenue
$5.16
Price to Book value
Price to Earnings
-$2.61
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$10.1M
Research & Development Expense
$41.9M
Total Operating Expenses
$-52M
Interest Expense
$-2.3M
Other Income / (Expense), net
$2.8M
Total Other Income / (Expense), net
$536K
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Mark J. Gergen
Location
California, USA
Exchange
Nasdaq
Website
https://poseida.com
Summary
Poseida Therapeutics, Inc.
Company Info
CEO
Mark J. Gergen
Location
California, USA
Exchange
Nasdaq
Website
https://poseida.com
Summary
Poseida Therapeutics, Inc.
